US 9675663
TUSC2 therapies
granted A61KA61K2039/505A61K31/517
Quick answer
US patent 9675663 (TUSC2 therapies) held by The Board of Regents of the University of Texas System expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K2039/505, A61K31/517, A61K31/7088, A61K31/7135